Elevance Health (ELV) Gains from Investment Securities (2009 - 2026)

Elevance Health (ELV) has 18 years of Gains from Investment Securities data on file, last reported at $34.0 million in Q1 2026.

• Gains from Investment Securities for Q1 2026 came in at $34.0 million, down 72.36% year-over-year; the trailing twelve-month figure through Mar 2026 was -$57.0 million (down 128.08% YoY), and the FY2025 annual result was $32.0 million, down 70.64% from the prior year.
• Gains from Investment Securities climbed to $34.0 million in Q1 2026 per ELV's latest filing, from $1.0 million in the prior quarter.
• Over five years, Gains from Investment Securities peaked at $123.0 million in Q1 2025 and troughed at -$85.0 million in Q2 2025.
• A 5-year average of $24.6 million and a median of $28.5 million in 2022 frame the typical range for Gains from Investment Securities.
• On a YoY basis, Gains from Investment Securities climbed as much as 473.33% in 2022 and fell as far as 300.0% in 2022.
• A 5-year view of Gains from Investment Securities shows it stood at $29.0 million in 2022, then jumped by 82.76% to $53.0 million in 2023, then tumbled by 75.47% to $13.0 million in 2024, then tumbled by 92.31% to $1.0 million in 2025, then surged by 3300.0% to $34.0 million in 2026.
• Business Quant data shows ELV's Gains from Investment Securities at $34.0 million in Q1 2026, $1.0 million in Q4 2025, and -$7.0 million in Q3 2025.